Cargando…
Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells
PURPOSE: Vascular endothelial growth factor (VEGF) is well known for its role in pathologic neovascularization, including wet age-related macular degeneration. However, a growing body of evidence indicates that VEGF is also neuroprotective of non-vascular cells in various animal models through reduc...
Autores principales: | Brar, Vikram S., Sharma, Rajesh K., Murthy, Ravi K., Chalam, K.V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956671/ https://www.ncbi.nlm.nih.gov/pubmed/21031022 |
Ejemplares similares
-
Effects of Indocyanine green on cultured retinal ganglion cells in-vitro
por: Balaiya, S, et al.
Publicado: (2009) -
Evaluation of ultraviolet light toxicity on cultured retinal pigment epithelial and retinal ganglion cells
por: Balaiya, Sankarathi, et al.
Publicado: (2010) -
Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
por: Sharma, Rajesh K., et al.
Publicado: (2010) -
Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab
por: Chalam, Kakarla V, et al.
Publicado: (2011) -
Functional microperimetry and SD-OCT confirm consecutive retinal atrophy from optic nerve pit
por: Brar, Vikram S, et al.
Publicado: (2009)